3022 - STARBURST: Phase 2 study of <sup>89</sup>Zr-girentuximab for PET imaging of solid tumors likely to express high levels of carbonic anhydrase IX (CAIX)

05:00pm - 06:00pm PT

Hall F

Presenter(s)

Frankis Almaguel, - Biogenix Molecular, Miami, FL